Three-dimensional collagen scaffolds coated with beta-tricalcium phosphate (β-TCP) nanoparticles reportedly exhibit good bioactivity and biodegradability. Dose effects of β-TCP nanoparticles on biocompatibility and bone forming ability were then examined. Collagen scaffold was applied with 1, 5, 10, and 25 wt% β-TCP nanoparticle dispersion and designated TCP1, TCP5, TCP10, and TCP25, respectively. Compressive strength, calcium ion release and enzyme resistance of scaffolds with β-TCP nanoparticles applied increased with β-TCP dose. TCP5 showed excellent cell-ingrowth behavior in rat subcutaneous tissue. When TCP10 was applied, osteoblastic cell proliferation and rat cranial bone augmentation were greater than for any other scaffold. The bone area of TCP10 was 7.7-fold greater than that of non-treated scaffold. In contrast, TCP25 consistently exhibited adverse biological effects. These results suggest that the application dose of β-TCP nanoparticles affects the scaffold bioproperties; consequently, the bone conductive ability of TCP10 was remarkable.
INTRODUCTION
Bone tissue engineering aims to create new functional bone via synergistic therapy using three biological elements 1) (cells [2] [3] [4] , signaling molecules [5] [6] [7] [8] , and natural and artificial scaffolds [9] [10] [11] ) in order to reverse bone loss caused by infectious disease [12] [13] [14] [15] , trauma 16) , and cancer 17) or to augment host bone for dental implants 18, 19) . Application of a three-dimensional (3D) scaffold to the bone defect produces a regenerative space for tissue reconstruction and stimulates cell proliferation and differentiation, along with angiogenesis and extracellular matrix secretion 20) . Therefore, refining the specifications of the regenerative scaffold is required for clinical upregulation of bone structure and function.
Bioceramics such as calcium phosphate and hydroxyapatite (HA) are widely known as bio-safe materials and bone graft substitutes 21, 22) . Nanomodification of biomaterials via nanosized bioceramics might play a major role in promoting their properties for biomedical applications [23] [24] [25] [26] . Ibara et al. and Ogawa et al. prepared a 3D collagen scaffold with surfacemodifications using beta-tricalcium phosphate (β-TCP) nanoparticles and subsequently implanted the scaffold in combination with fibroblast growth factor-2 (FGF-2) into rat connective tissue 27, 28) . They observed that the promotion of cell and tissue ingrowth into the scaffold was facilitated by β-TCP nanoparticle modification. Ogawa et al. also demonstrated that scaffolds loaded with β-TCP nanoparticles and FGF-2 accelerated reconstruction of periodontal organs, including alveolar bone, cementum, and periodontal ligament-like tissue, suggesting that scaffolds modified with β-TCP nanoparticles and FGF-2 can induce the formation of functional bone structures.
The applied dose of nanomaterial serves an important role in determining biocompatibility. Nanomaterials exhibit a high level of bioactivity. Therefore, adverse effects are expected to occur in biomedical applications. Huang et al. assessed the effects of applying HA nanoparticles (<100 nm) in vitro 29) . A high dose of HA nanoparticles stimulated the attachment and growth of osteoblastic cells, but it also induced lactate dehydrogenase production in macrophages, suggesting that HA is cytotoxic. Furthermore, Nishida et al. and Schrand et al. reported that the use of nanocarbons with a high nanocarbon to substrate ratio in biomaterials was associated with reduced cell viability 30, 31) . Therefore, we hypothesized that application of β-TCP nanoparticles at different Dose effects of beta-tricalcium phosphate nanoparticles on biocompatibility and bone conductive ability of three-dimensional collagen scaffolds content ratios would affect the biocompatibility and bone-forming ability of the 3D scaffold following implantation. This study was conducted to assess the dose effects of β-TCP nanoparticles on scaffold biological properties in vitro and in vivo. Additionally, we evaluated augmentation of rat cranial bone following implantation of scaffolds loaded with β-TCP nanoparticles at different doses.
MATERIALS AND METHODS

Fabrication and characterization of β-TCP nanoparticlemodified scaffolds
Dispersion of β-TCP nanoparticles was carried out as described previously 27) . β-TCP powder (Beta TCP; Tomita Pharmaceutical, Naruto, Japan) was pulverized into nano-sized particles using a pulverizer (Nanomizer, Yokohama, Japan). The peak profile of β-TCP powder via X-ray diffraction investigations was overlapped with the data of the previous report 27, 32) . The β-TCP nanoparticles, along with the surfactant sodium cholate (0.2 wt%), were then dispersed in 1-methyl-2-pyrrolidone (Wako Pure Chemical Industries, Osaka, Japan). Four nano-β-TCP dispersion doses (1, 5, 10, and 25 wt%) were used for application. The mean particle size of the β-TCP nanoparticles was 85 nm, as revealed by particle size distribution analysis (LB-550; Horiba, Kyoto, Japan).
Each β-TCP dispersion (100 µL) was injected into a 3D collagen scaffold (Terudermis ® , 6×6×3 mm 3 ; Olympus Terumo Biomaterials, Tokyo, Japan) using a syringe with a 25-gauge needle. Then the scaffold was immersed in ethanol to remove the dispersion solution. After several rinses in ethanol followed by air-drying, scaffolds were obtained for assessment and labeled respectively as TCP1, TCP5, TCP10, and TCP25 (Fig. 1A) . Collagen scaffold without β-TCP nanoparticle modification was also assessed as a control and was labeled as COL.
Surface nanostructures and cut sections of the scaffold were characterized using scanning electron microscopy (SEM, S-4000; Hitachi, Tokyo, Japan) with an accelerating voltage of 10 kV after coating with a thin layer of Pt-Pd. Chemical distribution mapping and composition analysis of the scaffolds with β-TCP nanoparticle modification were carried out using energy-dispersive X-ray spectrometry (EDS, JSM-6500F, 15 kV; JEOL, Tokyo, Japan) after coating with a thin layer of carbon. Compression tests for each scaffold were conducted using a universal testing machine (EZ-S; Shimadzu, Kyoto, Japan). The cross-head loading speed was set at 0.5 mm/min. The scaffold porosity was calculated using the following equation:
Porosity=100×(1−ρ1/ρ2), where ρ1=the bulk density and ρ2=the theoretical density of the scaffold. The bulk densities were calculated from measurements of the volumes and weights of β-TCP and collagen, respectively. The theoretical density was obtained from previous studies 33, 34) . Subsequently, each scaffold was subjected to in vitro enzymatic degradation testing. Pre-weighed dry specimens were immersed for 3 h at 37°C in phosphate-buffered saline (PBS) with 1% collagenase type I (0.1 mg/mL; Wako Pure Chemical Industries). After ethanol dehydration and air drying, the weight loss of the scaffold was determined. In addition, test of calcium ion release from the scaffolds were conducted. COL, TCP5, and TCP25 were immersed in PBS at 37°C. The calcium content after 7 days was measured in the supernatants using a calcium test kit (calciumE-test; Wako Pure Chemical Industries).
Cytocompatibility test
Mouse osteoblastic MC3T3-E1 cells (1×10 4 ; RIKEN BioResource Center, Tsukuba, Japan) were seeded onto the scaffolds and cultured in humidified 5% CO 2 at 37°C, using minimum essential medium (MEM) (alphaGlutaMAX™-I; Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS) (Qualified; Thermo Fisher Scientific) and 1% antibiotics (penicillin/streptomycin; Thermo Fisher Scientific). Cell viability was assessed after 1, 3, 5, and 7 days of culture using a WST-8 cell counting kit-8 (CCK-8; Dojindo Laboratories, Mashiki, Japan), in accordance with the manufacturer's instructions. The optical density was measured using a microplate reader at 450-nm absorbance. After 1 day of culture, some samples were fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) for 30 min and then rinsed in cacodylate buffer solution. Some samples were then dehydrated in increasing concentrations of ethanol. Following critical point drying, samples were analyzed using SEM.
Assessment of rat subcutaneous tissue responses
Animal experimental protocols followed the institutional animal use and care regulations of Hokkaido University (Animal Research Committee of Hokkaido University, approval number 10-42). Tenweek-old male Wistar rats weighing 190-210 g were given general anesthesia by intraperitoneal injections of 0.6 mL/kg sodium pentobarbital (Somnopenthyl; Kyoritsu Seiyaku, Tokyo, Japan), as well as a local injection of 2% lidocaine hydrochloride with 1:80,000 epinephrine (Xylocaine Cartridge for Dental Use; Dentsply Sankin, Tokyo, Japan). After a skin incision was made in back of each rat, each scaffold was implanted into the subcutaneous tissue. Skin flaps were sutured (Softretch 4-0; GC, Tokyo, Japan), and tetracycline hydrochloride ointment (Achromycin Ointment; POLA Pharma, Tokyo, Japan) was applied to the wound. Rats were euthanized by administration of an overdose of sodium pentobarbital (2.0 mL/kg) at 10 days post-surgery.
For DNA measurement (n=6), some specimens extracted from the wound were freeze-dried. Following pulverization, 0.5 mL of 2 M NaCl and 0.05 M phosphate buffer (pH 7.4) were added to each scaffold. After centrifugation, the DNA content of the infiltrated cells was measured using a DNA quantification kit (Primary Cell, Sapporo, Japan) according to the manufacturer's instructions, using a fluorescence spectrophotometer (F-3000; Hitachi) equipped with a 356-nm excitation filter and a 458-nm emission filter.
For histologic measurements (n=6), tissue blocks, including the surrounding soft tissues, were fixed in 10% buffered formalin, embedded in paraffin wax, and cut into 5-µm sections. Sections were stained with hematoxylin-eosin (HE) and observed histologically using light microscopy. Histomorphometric measurements of the residual scaffold and tissue ingrowth areas were performed using ImageJ software (ver. 1.41; National Institutes of Health, Bethesda, MD, USA). In addition, three area units (120 µm 2 per unit) were selected using light microscopy. The foreign body multinucleate giant cells around the β-TCP granules and collagen scaffold fibers at the periphery of the scaffolds were counted for three stained sections: one from the center of the excised tissue sample, and one each from tissue 1 mm to either side of the center.
Five rats receiving COL, TCP5, and TCP25 implantation were perfused via the aorta with physiologic saline, followed by 4% formaldehyde in 0.1 M phosphate buffer, pH 7.4. Tissue blocks were prefixed using 10% buffered formalin and then dipped in 30% sucrose solution. The tissues were embedded in OCT compound (Sakura Finetek Japan, Tokyo, Japan) and frozen quickly in liquid nitrogen. Frozen 16-μm sections were mounted on poly-L-lysine-coated glass slides. After pretreatment with 0.3% Triton X-100 and normal donkey serum, the sections were incubated overnight with the following primary antibodies, alone or in mixtures as indicated in the data: mouse anti-CD68 (1:100 dilution; AbD Serotec, Kidlington, UK), rabbit anti-galectin3 (gal3) (1:300 dilution, sc-20157; Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse anti-prolyl-4-hydroxylase beta (P4HB) (1:1600 dilution, clone6-9H6; Acris Antibodies, San Diego, CA, USA), mouse anti-rat endothelial cell antigen-1 (RECA-1) (1:1000 dilution; AbD Serotec), and mouse antialpha-smooth muscle actin (ASMA) (1:1600 dilution, clone 1A4; Sigma-Aldrich, St. Louis, MO, USA). The sites of antigen-antibody reaction were detected by incubation with Cy3-labeled anti-mouse IgG (Jackson Immuno Research Laboratories, West Grove, PA, USA) or AlexaFluor 488-labeled anti-rabbit IgG (Invitrogen, Eugene, OR, USA). Nuclear staining was performed by short incubation with TOTO3 (Invitrogen). The stained sections were mounted using glycerin-PBS and then observed under a confocal laser scanning microscope (Fluoview; Olympus, Tokyo, Japan). The specificity of the immunoreactions within the sections was confirmed according to a conventional procedure. Sections incubated with normal mouse or rabbit serum instead of respective primary antibody were used as negative controls. Subsequently, for detection of granulocytes, some sections were incubated in 0.01 M Tris-HCl buffer (pH 7.6) containing 0.01% 3,3´-diaminobenzidine (DAB) and 0.001% H 2O2. The stained sections were observed under light microscopy.
Bone-forming test
Forty-five 10-week-old male Wistar rats were given general anesthesia by intraperitoneal injections of sodium pentobarbital (0.6 mL/kg), as well as a local injection of 2% lidocaine hydrochloride with 1:80,000 epinephrine. After a skin incision was made in the scalp, a flap was made and decortication of a 4×4 mm area was performed in front of the coronal suture in the cranial bone using a rotating round bur under water irrigation. Subsequently, each scaffold was placed on the cranial bone with decortication. Skin flaps were sutured. Tetracycline hydrochloride ointment was then applied to the wound. Rats were euthanized using sodium pentobarbital (2.0 mL/kg). Specimens were collected from the wound 10 days (n=3) and 35 days (n=6) after surgery. The tissue blocks, including the cranial bone and surrounding soft tissue, were fixed in 10% buffered formalin, decalcified in 10% EDTA, embedded along the frontal plane in paraffin wax, and cut into 6-μm sections located every 300 µm. Sections were prepared and stained with HE and Masson's trichrome. In addition, some paraffin sections were examined for alkaline phosphatase (ALPase). After pretreatment with 0.3% H 2O2 and 1% bovine serum albumin (BSA; Serologicals Proteins, Kankakee, IL, USA) in PBS, the sections were incubated with rabbit antiserum against rat tissue nonspecific ALPase (1:100 in dilution) generated by Oda et al. 35) for 2 h. After rinsing, the sections were incubated with horseradish peroxidase-conjugated anti-rabbit IgG (Chemicon International, Temecula, CA, USA) for 1 h. For visualizing the immunoreaction, DAB tetrahydrochloride was used as a substrate. The stained sections were observed under light microscopy. Subsequently, three HE stained sections were taken for histomorphometric measurements from the midsection of the scaffold. Measurements of the areas of newly formed bone and residual scaffold were performed for each stained section after 35 days using a software package (Fig. 1B) .
Statistical analysis
Data are presented as the mean and standard deviation. Differences between groups were analyzed using the Scheffé test. Results for which p was <0.05 were regarded as statistically significant. All statistical analyses were performed using SPSS software (IBM SPSS 11.0; SPSS Japan, Tokyo, Japan).
RESULTS
Characterization of β-TCP nanoparticle-modified scaffolds
The SEM images in Figs. 2A-J show the nano-fine structure of the scaffolds modified by β-TCP nanodispersion. β-TCP nanoparticles attached well to the surface of collagen fibers of the scaffold, even in the central region of the collagen scaffold. In SEM images of TCP1 and TCP5, collagen fibers appear coated by a thin layer of dispersed β-TCP nanoparticles. TCP1 and TCP5 exhibited an interconnected structure similar to COL ( Figs. 2A-F) . In contrast, the collagen fibers were fully wrapped by a thick layer of aggregated β-TCP nanoparticles in TCP10 and TCP25. The inner space of the collagen scaffold was partly filled with aggregated β-TCP particles in TCP10 and TCP25 (Figs. 2G-J) . The porosity of each scaffold was calculated as >90% (Table  1) . However, TCP25 showed significantly lower porosity when compared to the other scaffolds. EDS analysis of the surface of scaffolds containing β-TCP nanoparticles showed the presence of oxygen, phosphorus, and calcium (Figs. 3A-E). The compression strength of TCP25 was enhanced strongly by application of β-TCP nanoparticles, approximately 2.5-fold greater than that of COL. The difference was statistically significant. In addition, the compression strengths of TCP5 and TCP10 were significantly greater (1.5-fold) when compared to COL (Fig. 4A) . In degradation tests, application of β-TCP nanoparticles to the scaffolds increased their resistance to enzymatic degradation. The decrement in the content of TCP25 scaffold after collagenase degradation was less compared with the other scaffolds (Fig. 4B ). Calcium ion release by the scaffold modified with β-TCP nanoparticles increased in a dose-dependent manner (Fig. 4C) .
Cytocompatibility test
After MC3T3-E1 cell seeding, marked cell spreading was demonstrated on the surface of scaffolds modified with β-TCP nanoparticles (Figs. 5A-E). In the SEM image of TCP1 and TCP5, cell processes appear elongated on the nano-fine structure consisting of collagen fibers and β-TCP nanoparticles (Figs. 5B and C). Although the surface of the collagen scaffold was mostly covered with a thick layer of aggregated β-TCP nanoparticles in TCP10 and TCP25, cell attachment and spreading were also demonstrated (Figs. 5D and E). In assessment of cytocompatibility, MC3T3-E1 cell proliferation on TCP1, TCP5, and TCP10 was stimulated significantly by β-TCP nanoparticle application in a dose-dependent manner when compared with COL. Particularly, TCP10 exhibited prominent proliferation. Similarly, cell proliferation on TCP25 was greater than on COL, although TCP25 showed decreased cell proliferation compared with TCP10 (Fig. 5F ).
Rat subcutaneous tissue responses
Greater cell ingrowth into the scaffold was observed in TCP1 and TCP5 when compared to COL (Figs. 6A-F) . The tissue-ingrowth area of TCP5 was significantly greater (3.5-fold) compared with COL (Fig. 7A ).
Immunohistochemical analysis of TCP5 revealed that macrophages expressing CD68 and gal3 and fibroblasts expressing P4HB were frequently found in the scaffold 
Rat bone forming test
At 10 days after implantation on cranial bone, TCP1, TCP5, and TCP10 were able to maintain the regenerative inner space and receive active cell infiltration. In contrast, COL appeared to be physically compressed (Figs. 9A-H) . TCP25 consistently induced biomaterialassociated inflammation, such as severe tissue swelling and the infiltration of leukocytes (Figs. 9I and J) . In specimens receiving TCP1, TCP5, and TCP10 at 35 days, marked dose-dependent bone augmentation continuous with the pre-existing bone occurred following application of β-TCP nanoparticles (Figs. 10A-H) . Newly formed bone frequently included collagen substrate, osteoblastic cells, and micro-aggregated β-TCP nanoparticle residue (Figs. 11A and B) . The bone area of TCP5 and TCP10 was, respectively, 5.3-and 7.7-fold greater than that of COL (Fig. 11C ). In addition, the amount of residual scaffold of TCP5 and TCP10 was significantly lower when compared with COL (Fig. 11D) . Conversely, TCP25
exhibited markedly limited bone augmentation on the cranial bone, irrespective of the application of a high dose of β-TCP (Fig. 10I) . Condensed β-TCP nanoparticles were demonstrated in the area of implanted scaffolds, but these particles seemed to have no relationship to bone formation (Fig. 10J) . The degree of bone formation of TCP25 was significantly less than that of TCP5 or TCP10 (Fig. 11C ).
DISCUSSION
In this study, surface modification with nano-fine structures such as β-TCP nanoparticles resulted in markedly increased bioactivity on 3D scaffolds made of collagen. Particularly, in vitro cell proliferation and in vivo cell and blood vessel ingrowth effects were strongly up-regulated, which is expected to guide tissue remodeling smoothly. We also found that application of a high dose of β-TCP nanoparticles to the scaffold adversely affected cell and tissue behaviors. Contrary to our expectations, TCP25 suppressed the proliferation of MC3T3-E1 cell in cultures when compared with lowdose application of β-TCP nanoparticles (i.e., TCP10). In addition, histologic analyses revealed that specimens receiving scaffolds with high-dose β-TCP modification, especially TCP25, exhibited low tissue affinity after implantation in rats, as evidenced by macrophage aggregation and severe inflammation, leading to abnormal healing. Fabricated scaffolds consisting only of bovine atelocollagen and β-TCP as the artificial substrate are generally recognized as biosafe materials 36, 37) . Accordingly, we hypothesized that some physical and chemical properties of the scaffolds nano-modified with β-TCP were associated with the observed adverse biological effects. In SEM observation, TCP25 showed a thick layer of β-TCP nanoparticles that thoroughly coated the collagen scaffold surface. Therefore, the cell attachment apparatus could not stably attach to the base strut of the collagen scaffold, suggesting that the unstable structure used as scaffolding affected cell proliferation. Calcium release test produced evidence that TCP25 released higher levels of calcium ion than the other scaffolds. Maeno et al. revealed earlier that osteoblast viability, such as growth and survival rate, was decreased by the application of high concentrations of calcium ions, demonstrating a dose-dependent inverse effect of calcium ions on cell activity 38) . Sugimoto et al. reported that high calcium ion concentrations stimulated chemotactic responses in monocytes, associated with macrophage differentiation and inflammatory responses, as well as osteoblastic cell proliferation 39) . These reports are consistent with our results showing that the numbers of CD68-positive cells and giant cells increased in specimens receiving a high dose of β-TCP nanoparticles, demonstrating that calcium ion release from β-TCP scaffolds might play a major role in cellular response and function following scaffold implantation.
Watari et al. reported a nanosizing effect when nanomaterial was applied in the body 40) . For instance, the production of superoxide in relation to cellular phagocytosis increased with a subsequent decrease in titanium (Ti) particle size, especially below 10 µm. They also reported that in human neutrophils, Ti particles smaller than 10 µm promoted production of IL-1β and TNF-α, which are related to tissue inflammation. However, these phenomena occurred to a lesser degree for particles smaller than 200 nm. The particle size distribution analyses in the present study showed that β-TCP nanoparticles were approximately 100 nm in diameter. However, SEM images of TCP25 frequently showed aggregation of nanoparticles. The application of high doses of nano-sized β-TCP dispersion created micrometer-sized secondary particles by agglutination, thereby stimulating inflammatory responses and phagocytosis by macrophages. In fact, TCP25 application consistently caused swelling and inflammatory cell infiltration both in rat subcutaneous tissue and cranial bone tests.
Examination of the scaffold physical properties revealed that the compressive strength and collagenase resistance was increased in a dose-dependent manner by the application of β-TCP nanoparticles, suggesting that a thick coating layer consisting of β-TCP nanoparticles and the resulting attractive forces associated with the nanoscale distance between particles enhanced the collagen-based scaffold stability. In bone regenerative therapy, mechanical stiffness of the scaffold can play an important role in maintaining the inner tissuereconstructive space for osteogenic cells such as osteoblasts 41, 42) . Regenerative scaffolds should be designed to provide a highly porous structure for the stimulation of tissue ingrowth. However, higher porosity is generally associated with lower mechanical strength 43, 44) . SEM images of TCP5 exhibited evidence of an interconnected porous structure in relation to high porosity, but images of TCP25 showed that the porous space was partly filled with clumps of aggregated TCP nanoparticles. We hypothesized that these results also indicate decreased cellular ingrowth behavior and subsequent bone formation in rats. In fact, numerous giant cells were observed around the aggregated β-TCP granules in the specimens receiving TCP25; therefore, tissue ingrowth might be promoted following severe degradation of β-TCP granules. A regenerative scaffold modified with β-TCP nanoparticles at an optimal dose and exhibiting the excellent porous structure of TCP5 could play an important role in tissue engineering.
The results of bone-forming assessments in rats revealed that bone augmentation was promoted to a considerable degree, compared to COL, by provision of TCP5 or TCP10. However, TCP25 consistently exhibited slight bone formation after implantation, similar to COL-treated histologic specimens. Many previous investigators have reported that β-TCP possesses good osteoconductivity and degradability as a bone graft material when implanted into the bone tissue. They also reported that β-TCP phagocytosis provides calcium ions for osseous induction following osteoblast proliferation [45] [46] [47] . As described above, TCP25 strongly induced release of calcium ions, irrespective of macrophage phagocytosis. Therefore, an overdose of calcium ions in the bone-forming field is expected to decrease osteoblastic activity 39, 48, 49) . In addition, histologic analysis of specimens from TCP25 implantation at 10 days showed severe inflammatory responses, such as swelling. Therefore, high doses of β-TCP nanoparticles negatively affect the biocompatibility of the scaffold for bone tissue engineering. Subsequently, bone augmentation would not be provided. Interestingly, although TCP10 exhibited adverse effects such as prominent macrophage aggregation in subcutaneous tissue, it exhibited positive effects on bone augmentation in cranial bone. Therefore, we presumed that the bioactivity of β-TCP nanoparticles is site specific. Furthermore, β-TCP in combination with several growth factors promoted prominent bone formation as well as cell proliferation and neovascularization 50, 51) . Therefore, additional investigations must be conducted to facilitate further development of β-TCP nanoparticle therapy.
CONCLUSION
Dose effects of β-TCP nanoparticles applied to 3D collagen scaffolds were examined in vitro and in vivo.
Application of β-TCP nanoparticles enhanced the physical properties of the scaffold. TCP5 implantation promoted cell-ingrowth behavior and new blood vessel formation in subcutaneous tissue. Osteoblastic cell proliferation and rat bone augmentation by TCP10 were greater than for any other scaffold. However, TCP25 consistently exhibited adverse biological effects. These results suggest that the application dose of β-TCP nanoparticles affects scaffold biocompatibility and bone conductive ability and suggest that β-TCP nanoparticle therapy using TCP5 and TCP10 shows the greatest potential for use in bone tissue engineering.
